Elsevier Health expands access to ClinicalKey AI to individual medical residents and physicians

Elsevier Health 新しいタブ／ウィンドウで開く, a global leader in medical information and data analytics, today announced the expansion of ClinicalKey AI to individual medical residents and physicians across the US to better support clinical decision-making at the point of care.

Access to trusted, evidence-based medical information is of the utmost importance to time-pressed physicians. ClinicalKey AI, now available to individual residents and physicians through a monthly or annual subscription, addresses this challenge by leveraging a sophisticated conversational search interface to deliver accurate, succinct clinical information. The solution has been designed to provide high-quality curated content and constantly refreshed evidence-based research to help physicians make clinical decisions and improve the patient experience.

The expansion of ClinicalKey AI is based on valuable feedback from physicians who are keen to utilize AI tools in a responsible manner. In Elsevier’s 2024 Insights Toward AI Report 新しいタブ／ウィンドウで開く, which includes the latest insights from nearly 3,000 researchers and clinicians, 96% of clinicians believe AI will help accelerate knowledge discovery and 88% believe AI will help increase work quality overall.

Louise Chang, MD, Global VP, Digital Content Strategy and Partnerships, Elsevier Health said: "Physicians continue to face challenges with resource constraints, time pressure and data overload and we aim to address these challenges by simplifying their access to relevant, evidence-based information through an AI tool they can trust. ClinicalKey AI is a fast and easy clinical support tool that brings together best-in class content with technology enabling a new level of accessibility to information and insights.”

For more than two decades, Elsevier has been using AI and machine learning technologies in combination with our world-class peer-reviewed content and extensive data sets to create solutions that help the research, life sciences and healthcare communities be more effective every day

To learn more about ClinicalKey AI, please click here 新しいタブ／ウィンドウで開く.

About Elsevier Health

For more than 140 years, Elsevier has supported the work of researchers and healthcare professionals by providing current, evidence-based information that can help empower students and clinicians to provide the best healthcare possible. Growing from our roots, Elsevier Health applies innovation, facilitates insights, and helps drive more informed decision-making for our customers across global health. We support health providers by providing accessible, trusted evidence-based information to take on the infodemic; prepare more future health professionals with effective tools and resources; provide insights that help clinicians improve patient outcomes; deliver healthcare that is truly inclusive; and supports a more personalized and localized healthcare experience.

Diversity and inclusion are the foundation of our innovation, and our teams are committed to creating education and practice solutions that reflect the diversity of our world. Elsevier Health is helping lay the groundwork for more equitable healthcare worldwide. We bring the same rigor to our digital information solutions as we do to our publishing, allowing us to offer knowledge and valuable analytics that help our users make breakthroughs and drive progress for the benefit of every patient.

エルゼビアについて エルゼビアは、科学情報と分析を牽引するグローバル企業として、研究者や医療従事者が社会の利益のために科学を進歩させ、医療成果を向上させることを支援しています。我々は信頼できるエビデンスベースのコンテンツと高度なAI対応デジタルテクノロジーに基づくソリューションにより、インサイトと重要な意思決定を促進することでこれを実現しています。

エルゼビアは、140 年以上にわたり研究および医療コミュニティの活動を支援してきました。全世界で 2,500 人以上の技術者を含む 9,500 人の従業員がおり、重要な職務における研究者や、図書館員、アカデミックリーダー、資金提供者、政府機関、R&D 関連企業、医師、看護師、将来の医療従事者や教育者を支援することに従事してきました。2,900 誌以上の科学ジャーナルと代表的な参考文献には、Cell Press、The Lancet、Gray's Anatomy など、各分野の主要なタイトルを含みます。 エルゼビア・ファウンデーション 新しいタブ／ウィンドウで開くと共に、開発途上国および世界中の科学、研究、医療分野におけるインクルージョン＆ダイバーシティ 新しいタブ／ウィンドウで開くを推進するため、支援コミュニティと連携して活動しています。 エルゼビアは、プロフェッショナルおよびビジネス顧客向けの情報に基づく分析および意思決定ツールのグローバルプロバイダーである RELX 新しいタブ／ウィンドウで開くグループの一部です。業務内容やデジタルソリューション、コンテンツ詳細については、 www.elsevier.com/ja-jpをご参照ください。